Literature DB >> 25579854

Sirtuin function in aging heart and vessels.

Chiara Cencioni1, Francesco Spallotta2, Antonello Mai3, Fabio Martelli4, Antonella Farsetti5, Andreas M Zeiher6, Carlo Gaetano7.   

Abstract

Age is the most important risk factor for metabolic alterations and cardiovascular accidents. Although class III histone deacetylases, alias Sirtuins, have been appealed as "the fountain of youth" their role in longevity control and prevention of aging-associated disease is still under debate. Indeed, several lines of evidence indicate that sirtuin activity is strictly linked to metabolism and dependent on NAD(+) synthesis both often altered as aging progresses. During aging the cardiovascular system is attacked by a variety of environmental stresses, including those determined by high blood glucose and lipid levels, or by the presence of oxidized lipoproteins which, among others, determine important oxidative stress signals. In such a milieu, heart and vessels develop a functional impairment leading to atherosclerosis, ischemia, heart insufficiency and failure. Sirtuins, which are believed to have a positive impact on cardiovascular physiology and physiopathology, are distributed in different subcellular compartments including the nucleus, the cytoplasm and the mitochondria, where they regulate expression and function of a large variety of target genes and proteins. Remarkably, experimental animal models indicate resveratrol, the first natural compound described to positively regulate the activity of sirtuins, as able to protect the endothelium and the heart exposed to a variety of stress agents. This review will focus on the regulation and function of mammalian sirtuins with special attention paid to their role as cardiovascular "defenders" giving indication of their targets of potential relevance for the development of future therapeutics. This article is part of a Special Issue entitled CV Aging.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetylation; Aging; Endothelium; Metabolism; Myocardium; Sirtuins

Mesh:

Substances:

Year:  2015        PMID: 25579854     DOI: 10.1016/j.yjmcc.2014.12.023

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  26 in total

Review 1.  So! What's aging? Is cardiovascular aging a disease?

Authors:  Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

Review 2.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 3.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

Review 4.  Arterial structure and function in vascular ageing: are you as old as your arteries?

Authors:  Dick H J Thijssen; Sophie E Carter; Daniel J Green
Journal:  J Physiol       Date:  2015-07-27       Impact factor: 5.182

Review 5.  Mitochondrial redox status as a target for cardiovascular disease.

Authors:  James W Walters; Deborah Amos; Kristeena Ray; Nalini Santanam
Journal:  Curr Opin Pharmacol       Date:  2016-02-16       Impact factor: 5.547

Review 6.  Mitochondrial Metabolism in Aging Heart.

Authors:  Edward J Lesnefsky; Qun Chen; Charles L Hoppel
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 7.  Hemodynamic characteristics and early warnings in very old patients.

Authors:  Hui Lian; Xin Ding; Hongmin Zhang; Dawei Liu; Xiaoting Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 8.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

Review 9.  Epigenetic regulation in heart failure.

Authors:  Soo Young Kim; Cyndi R Morales; Thomas G Gillette; Joseph A Hill
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

10.  Redd1 knockdown prevents doxorubicin-induced cardiac senescence.

Authors:  Pianpian Huang; Lijuan Bai; Lihua Liu; Jun Fu; Kefei Wu; Hongxia Liu; Yun Liu; Benming Qi; Benling Qi
Journal:  Aging (Albany NY)       Date:  2021-05-06       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.